Revorf
株式会社Revorf is a Japanese company operating in the infectious disease and autoimmune disease sectors. They aim to contribute to people's health by integrating information analysis technology with their proprietary bio-technology. Their business activities include testing, diagnostics development support, and drug discovery support. A key focus is their neo-self antibody testing, particularly for infertility and habitual miscarriage, which is based on the neo-self theory explaining the root cause of autoimmune diseases. They also utilize bio-information analysis technology for drug discovery, collaborating with Toshiba Digital Solutions on allosteric drug discovery using their quantum-inspired optimization solution (SQBM+TM). The company was founded in November 2019 and aims to create a world where people's normal health is not threatened.
Revorf
株式会社Revorf is a Japanese company operating in the infectious disease and autoimmune disease sectors. They aim to contribute to people's health by integrating information analysis technology with their proprietary bio-technology. Their business activities include testing, diagnostics development support, and drug discovery support. A key focus is their neo-self antibody testing, particularly for infertility and habitual miscarriage, which is based on the neo-self theory explaining the root cause of autoimmune diseases. They also utilize bio-information analysis technology for drug discovery, collaborating with Toshiba Digital Solutions on allosteric drug discovery using their quantum-inspired optimization solution (SQBM+TM). The company was founded in November 2019 and aims to create a world where people's normal health is not threatened.